Carboplatin/paclitaxel

Carboplatin/paclitaxel Reactions 1704, p86 - 2 Jun 2018 Thrombocytopenia: case report In a retrospective chart review of 27 women (aged 45 76 years), one woman was described [age not stated], who developed thrombocytopenia following treatment with carboplatin and paclitaxel for ovarian cancer [routes, duration of treatments to reaction onset and outcome not stated]. The woman, who had stage I/II ovarian cancer, started receiving treatment with paclitaxel 100 mg/m on days 1 and 11 along with carboplatin (AUC 6) every three weeks. She developed grade 3 thrombocytopenia. Author comment: "Stage I and II ovarian cancer patients who only received adjuvant divided-dose therapy, four required dose reductions, four had grade 4 neutropenia, and one had grade 3 thrombocytopenia." Kudlowitz D, et al. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naive women with high-grade epithelial cancers of Mullerian origin. Cancer Chemotherapy and Pharmacology 81: 847-851, No. 5, May 2018. Available from: URL: https://doi.org/10.1007/ s00280-018-3559-y - USA 803323454 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Carboplatin/paclitaxel

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/carboplatin-paclitaxel-UZyXLl6big
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46729-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p86 - 2 Jun 2018 Thrombocytopenia: case report In a retrospective chart review of 27 women (aged 45 76 years), one woman was described [age not stated], who developed thrombocytopenia following treatment with carboplatin and paclitaxel for ovarian cancer [routes, duration of treatments to reaction onset and outcome not stated]. The woman, who had stage I/II ovarian cancer, started receiving treatment with paclitaxel 100 mg/m on days 1 and 11 along with carboplatin (AUC 6) every three weeks. She developed grade 3 thrombocytopenia. Author comment: "Stage I and II ovarian cancer patients who only received adjuvant divided-dose therapy, four required dose reductions, four had grade 4 neutropenia, and one had grade 3 thrombocytopenia." Kudlowitz D, et al. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naive women with high-grade epithelial cancers of Mullerian origin. Cancer Chemotherapy and Pharmacology 81: 847-851, No. 5, May 2018. Available from: URL: https://doi.org/10.1007/ s00280-018-3559-y - USA 803323454 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off